Cipla, Pulmatrix join hands to co-develop Pulmazole for treating asthma Garima16 April 2019 9:40 AM ISTPulmazole an inhaled iSPERSE formulation of the antifungal drug itraconazole for the treatment of allergic bronchopulmonary aspergillosis (ABPA) in...
Cipla signs over Rs 152 crore pact with Pulmatrix for new asthma drug Pulmazole Garima2 April 2019 9:45 AM ISTThe agreement has been signed between the company's wholly-owned subsidiary in the US, Cipla Technologies LLC with Pulmatrix Inc for investment in...